As part of its ongoing operational review and commitment to institutional excellence, Zein Pharma Pharmaceutical Industries convened its periodic meeting for members of its scientific offices. The session was dedicated to reviewing key achievements from the first quarter (Q1), evaluating market performance and sales indicators, and discussing strategic opportunities and operational challenges for the upcoming...

Under the sponsorship of Zein Pharma Pharmaceutical Industries, a scientific launch symposium was held in Hama Governorate to introduce Vonozein (Vonoprazan 10–20 mg). The symposium brought together a distinguished gathering of leading physicians, gastroenterologists, and healthcare professionals from across the governorate for an in-depth clinical dialogue on modern approaches to managing acid-related disorders and Gastroesophageal...

Zein Pharma Pharmaceutical Industries had the honor of welcoming an official delegation from the European Union (EU in Syria) at the company’s headquarters. The high-level visit provided a valuable platform for constructive dialogue on the essential role played by national pharmaceutical manufacturing in supporting public health infrastructure, securing local medical supply chains, and meeting patient...